Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1304 | 1106 | 1418 | 1312 | 2280 | 4782 |
Fund Return | 30.45% | 10.63% | 41.81% | 9.46% | 17.92% | 16.94% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AGF American Growth Class Series T | 3.97B | 32.40 | 13.35 | 15.36 | ||
AGF American Growth Class CAD | 3.97B | 33.06 | 13.48 | 15.33 | ||
AGF Global Dividend Fund CAD | 2.42B | 18.14 | 9.49 | 8.26 | ||
AGF Global Dividend Fund Series CAD | 2.42B | 19.30 | 10.77 | 9.52 | ||
AGF Global Dividend Fund Series Q | 2.42B | 20.56 | 12.13 | 10.85 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 14.31B | 43.16 | 12.27 | - | ||
Mawer Global Equity | 13.94B | 8.62 | 5.37 | 10.93 | ||
Capital Group Glbal Equity Fd F CAD | 13.86B | 22.86 | 3.88 | 11.66 | ||
Capital Group Glbal Equity Fd A CAD | 13.86B | 21.74 | 2.74 | 10.43 | ||
Capital Group Glbal Equity Fd D CAD | 13.86B | 22.55 | 3.53 | 11.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 7.82 | 146.80 | +0.36% | |
Amazon.com | US0231351067 | 6.60 | 211.48 | -1.22% | |
Boston Scientific | US1011371077 | 4.71 | 87.59 | -1.33% | |
Intuitive Surgical | US46120E6023 | 4.71 | 537.91 | +0.23% | |
On Holding | CH1134540470 | 4.35 | 53.35 | +1.21% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review